RE:Webcast Aug 4 Thanks...
Any updates given re: the status of that sublingual strip/transmucosal delivery patent? Once/if granted, having rights/ownership to such a patent would potentially do wonders for their other proprietary drugs for which they've filed provisional apps (I.e. utilizing/crossing over to a more practical form of drug delivery for clinical trials, which would translate well for "real world" outpatient use).
As far as I know, their original strip delivery patent process (invented by Dr. Sanderson) has been several years in the making now...still waiting. I believe it had included at least one modified or 2nd provisional app being filed. Let's hope these new provisional apps/future apps get filed as "non-provisional" apps in a more timely/less risky manner.
By the way, does COOL still have rights/ownership of their first "pending" patent (the one for the strip technology)? Is Dr. Sanderson even still involved with this company?